Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Mitochondrial dysfunctions in 7-ketocholesterol-treated 158N oligodendrocytes without or with α-tocopherol: Impacts on the cellular profil of tricarboxylic cycle-associated organic acids, long chain saturated and unsaturated fatty acids, oxysterols, chol
Editorial: Glial Cells: Managers of Neuro-Immunity.
Allelic imbalance of multiple sclerosis susceptibility genes IKZF3 and IQGAP1 in human peripheral blood.
Label free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis.
Neuroprotective effect of melatonin in experimental optic neuritis in rats.
Development of a Short Version of MSQOL-54 Using Factor Analysis and Item Response Theory.
Estrogen treatment of experimental autoimmune encephalomyelitis requires E2 receptor positive B cells that upregulate PD-1 on CD4(+) Foxp3(+) Treg cells.
Multiple sclerosis: Fatigue-a warning sign for multiple sclerosis?
[Semaphorin 4 in multiple sclerosis].
The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
The BICAMS Battery for Assessment of Lithuanian-Speaking Multiple Sclerosis Patients: Relationship with Age, Education, Disease Disability, and Duration.
CCRL2 regulates M1/M2 polarization during EAE recovery phase.
Nurse-led clinics for patients with chronic diseases in hospital and transmural care organizations.
Correction: Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis.
Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis.
Increased activation of the epidermal growth factor receptor in transgenic mice overexpressing epigen causes peripheral neuropathy.
Influence of multiple sclerosis, age and degree of disability, in the position of the contrast sensitivity curve peak.
More on JC viremia in natalizumab-treated patients with multiple sclerosis.
Erythrocytes' antioxidative capacity as a potential marker of oxidative stress intensity in neuroinflammation.
Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing.
A Novel MPZ Gene Mutation in Exon 2 Causing Late-Onset Demyelinating Charcot-Marie-Tooth Disease.
Combining Double Fluorescence In Situ Hybridization with Immunolabelling for Detection of the Expression of Three Genes in Mouse Brain Sections.
Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity.
Case report of transverse myelitis in a patient receiving etanercept for rheumatoid arthritis.
Interferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients.
Pages
« first
‹ previous
…
665
666
667
668
669
670
671
672
673
…
next ›
last »